U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07171879) titled 'Pontic Shield and Mineralized Plasmatic Matrix for Ridge Preservation: A Randomized Clinic... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07171840) titled 'Effectiveness of Intra-articular Oxygen-ozone Injections and Splinting for the Treatment o... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07172867) titled 'A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide i... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173322) titled 'The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey' on Aug. 29. Brief Summar... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07172724) titled 'Clinical Trial to Evaluate the Safety and Immunogenicity of the Vivaxin Vaccine for Malari... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07172269) titled 'Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Iraqi Patients Wit... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07174388) titled 'Prospective External Controls in Non-Small Cell Lung Cancer' on Sept. 12. Brief Summary: ... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173556) titled 'A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanc... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07174154) titled 'Qualitative Study Among Migrant and Socially Vulnerable Populations on Their Interest in C... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07172256) titled 'CUE-101with Pembrolizumab for LA-HPV+HNSCCs' on Sept. 03. Brief Summary: This is a phase ... Read More